Dec 26, 2023 | Alternative Reimbursement Strategies, Benefits preservation, Client Feedback, Client Surveys, Fair Market Pricing, ISO, Kurt Harden, MedBen Connect, MedBen Rx, President's Note
On behalf of the MedBen team, I wish you a happy and prosperous new year and thank you for your continued trust in MedBen. In 2023, we celebrated our 85th Anniversary. Those years have been marked by a variety of challenges and successes but I am particularly...
Sep 1, 2023 | Announcements, ISO, Kurt Harden, News, Quality
MedBen has successfully completed a re-assessment audit of its ISO 9001 procedures and has achieved recertification, according to company President and CEO Kurt Harden. Independent auditors from ISO consulting firm Intertek reviewed MedBen’s compliance with...
May 16, 2023 | Alternative Reimbursement Strategies, Announcements, Case Studies, Client Report, Client Services, Client Surveys, Communication, Compliance, Cost Plus Pricing, Cost Savings, Direct-to-Employer Contracting, Drug costs, Forensic claims review, HealthJoy, Inflation, Kurt Harden, MedBen Rx, MedBen WellLiving, Member engagement, Mobile App, Online Services, Own Use, Pharmacy, Pharmacy Benefits Manager (PBM), Plan Design, Plan Language, Prescription, Reference-Based Pricing, Regulatory, Rx Costs, Savings, Self-funding, Specialty Drugs, Supreme Court, Wellness
The 2023 MedBen Client Report is now available to download from MedBen.com! In his opening note, MedBen President Kurt Harden states: “This Client Report is designed to demonstrate ways that clients can generate greater value from their health plan. With health...
Apr 14, 2023 | Announcements, Client Report, Direct-to-Employer Contracting, Kurt Harden, MedBen Rx, Member engagement, Supreme Court
In the upcoming 2023 MedBen Client Report, we’ll be looking at some of the issues that affected our clients last year, and the ways we worked with them to find successful solutions to preserve or improve their benefits. “With health care inflation expected...
Mar 21, 2023 | Brand Name Drugs, Diabetes, Drug costs, Generic Drugs, Insulin, Kurt Harden, MedBen Rx, MedBen University, Pharmacy Benefits Manager (PBM), Prescription
Earlier this month, drug manufacturer Eli Lilly announced that it cutting the cost of two of its prescription brand insulins, Humalog and Humulin, by 70%, and capping out-of-pocket costs for privately insured patients at $35 a month. Competing drugmakers Novo Nordisk...
Mar 3, 2023 | Announcements, Columbus Business First, Direct-to-Employer Contracting, Kurt Harden, MedBen News, News
MedBen has once again topped the list of Largest Central Ohio Employee Benefits Companies as ranked by Columbus Business First. “We’re celebrating our 85th anniversary this year, and the main reason for this longevity is our people,” said MedBen President and CEO Kurt...
